Because sgRNAs targeting ASTILCS bind PTP4A3 between 512 and 611 bp away from the transcription start site, there is a possibility that the sgRNA–dCas9–KRAB complex hinders PTP4A3 mRNA expression, resulting in HCC cell death independently of ASTILCS. The gene discussed is PTP4A3; the disease is hepatocellular carcinoma.